Truist Financial Corp Sarepta Therapeutics, Inc. Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 1,729 shares of SRPT stock, worth $225,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,729

Previous 4,003 56.81%

Holding current value

$225,634

Previous $632,000 65.98%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$124.33 - $156.75 $282,726 - $356,449	-2,274 Reduced 56.81%	1,729 $215,000
Q2 2024 Aug 20, 2024	BUY	$113.33 - $163.85 $210,453 - $304,269	1,857 Added 86.53%	4,003 $632,000
Q1 2024 May 10, 2024	SELL	$93.7 - $141.53 $40,291 - $60,857	-430 Reduced 16.69%	2,146 $277,000
Q4 2023 Feb 02, 2024	SELL	$67.31 - $124.76 $11,308 - $20,959	-168 Reduced 6.12%	2,576 $248,000
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $281,260 - $339,130	2,744 New	2,744 $332,000
Q1 2022 Apr 22, 2022	SELL	$63.15 - $90.42 $181,998 - $260,590	-2,882 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $114,606 - $147,439	-1,483 Reduced 33.97%	2,882 $260,000
Q3 2021 Nov 05, 2021	BUY	$65.97 - $92.48 $94,007 - $131,784	1,425 Added 48.47%	4,365 $404,000
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $110,938 - $138,713	-1,599 Reduced 35.23%	2,940 $229,000
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $411,174 - $961,494	-5,691 Reduced 55.63%	4,539 $339,000
Q4 2020 Nov 19, 2021	SELL	$125.56 - $178.74 $337,756 - $480,810	-2,690 Reduced 20.82%	10,230 $1.74 Million
Q4 2020 Feb 18, 2021	BUY	$125.56 - $178.74 $2,511 - $3,574	20 Added 0.16%	12,920 $2.2 Million
Q3 2020 Nov 13, 2020	BUY	$127.12 - $172.34 $598,608 - $811,549	4,709 Added 57.49%	12,900 $1.81 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $11,253 - $20,775	121 Added 1.5%	8,191 $1.31 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $132,549 - $211,808	-1,609 Reduced 16.62%	8,070 $790,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $395,124 - $699,999	5,163 Added 114.33%	9,679 $1.25 Million
Q3 2019 Oct 31, 2019	BUY	$72.81 - $156.91 $8,081 - $17,417	111 Added 2.52%	4,516 $340,000
Q2 2019 Jul 24, 2019	BUY	$112.21 - $151.95 $16,046 - $21,728	143 Added 3.36%	4,405 $669,000
Q1 2019 Apr 23, 2019	BUY	$106.67 - $151.68 $49,921 - $70,986	468 Added 12.34%	4,262 $508,000
Q4 2018 Jan 22, 2019	BUY	$97.32 - $148.76 $29,877 - $45,669	307 Added 8.8%	3,794 $414,000
Q3 2018 Oct 17, 2018	BUY	$115.31 - $161.51 $58,116 - $81,401	504 Added 16.9%	3,487 $563,000
Q2 2018 Jul 26, 2018	BUY	$71.74 - $153.69 $214,000 - $458,457	2,983 New	2,983 $394,000

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Sarepta Therapeutics, Inc. Transaction History